Jco Precision Oncology

杂志介绍

Jco Precision Oncology杂志介绍

《Jco Precision Oncology》是一本以English为主的混合获取国际优秀期刊，中文名称Jco精准肿瘤学，本刊主要出版、报道医学-肿瘤学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为4.7，最新CiteScore 指数为6.2。

本刊近期中国学者发表的论文主要有：

• Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substud

  Author: Duan, Yuqing; Hashimoto, Tadayoshi; Shibuki, Taro; Taniguchi, Hiroya; Sunakawa, Yu; Komatsu, Yoshito; Takahashi, Naoki; Sato, Yuta; Yamaguchi, Kensei; Nishina, Tomohiro; Nakanoko, Tomonori; Boku, Shogen; Satoh, Taroh; Yasui, Hisateru; Esaki, Taito; Imai, Mitsuho; Fujisawa, Takao; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki

• Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics Analysi

  Author: Liu, Pengcheng; Chen, Zhongxu; Hong, Hui; Sun, Yihua

• Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective Analysi

  Author: Lin, Ke; Wang, Cailun; Qiao, Bin; Zhang, Nan; Yang, Daopeng; Jin, Dongdong; Li, Cong; Lv, Jingsen; He, Minghui; Lin, Zhao; Xie, Xiaohua; Xie, Xiaoyan; Zhuang, Bowen

• Foundation Model Based on Routine Magnetic Resonance Imaging for Brain Tumor Molecular Profiling and Progression Predictio

  Author: Li, Junxian; Liu, Renhe; Xing, Yuchen; Gao, Ximin; Yin, Qiang; Su, Qian

英文介绍

Jco Precision Oncology杂志英文介绍

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).